Fundraising FoxDestiny-Pharma
3 known investors
Find your way into Destiny-Pharma
Sign up to see every warm intro you have to Destiny-Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Destiny-Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AMR Bio is a clinical-phase biotechnology company developing novel anti-infective drugs focused on infection prevention and combating antibiotic resistance.
Investors · 3
Juno Capital Partnerslisted by Juno Capital PartnersLondon
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Destiny-Pharma do?
- AMR Bio is a clinical-phase biotechnology company developing novel anti-infective drugs focused on infection prevention and combating antibiotic resistance.
- Who are Destiny-Pharma's investors?
- Destiny-Pharma's investors include Juno Capital Partners, Rosetta Capital Ltd., Seneca Partners.